Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 2 minute read Pharma Industry News Novartis reports significant proteinuria reduction by Fabhalta in Phase 3 IgAN trial Novartis has shared encouraging results from the Phase III APPLAUSE-IgAN study, revealing that Fabhalta (iptacopan) led to a… byPallavi MadhirajuApril 18, 2024